Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > About KCI > News & Media > Media Information > Corporate Profile > KCI's TSS Business Unit Announces First Non-Foam-Based Pressure Redistribution Surface Available in U.S. for Patients up to 1000 Pounds

KCI's TSS Business Unit Announces First Non-Foam-Based Pressure Redistribution Surface Available in U.S. for Patients up to 1000 Pounds

Released : May 17th 2011

AtmosAir Fit MRS Sets a New Benchmark in the Challenge to Ensure Skin Integrity and Pressure Ulcer Prevention for Morbidly Obese Patients

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO—May 17, 2011— Kinetic Concepts, Inc. (NYSE:KCI) announced today that it will significantly enhance its product offering for the care of obese patients by making its AtmosAir Fit Mattress Replacement System (MRS) standard on the company's BariMaxx II Bed. The AtmosAir Fit MRS uses a proprietary, air-driven pressure redistribution method for patients weighing up to 1000 pounds, offering an improvement over foam-based pressure redistribution technologies. By combining the AtmosAir Fit MRS with the BariMaxx II Bed, more patients can now receive continuous pressure redistribution therapy.

The AtmosAir family of products, launched by KCI in 1999, is the standard of care for many hospitals across the country as the baseline defense against pressure ulcers, which are costly and avoidable never events. While other products in this sector largely consist of foam for pressure redistribution, the AtmosAir Fit MRS is the first and only non-powered, bariatric surface that doesn't rely primarily on foam for pressure redistribution therapy.

"The AtmosAir Fit MRS, in combination with the BariMaxx II Bed, creates a new standard of care in the safe and dignified treatment of bariatric patients," said Stephen Seidel, global president, KCI Therapeutic Support Systems. "Our confidence in the AtmosAir line of products and their clinical use in helping to prevent skin breakdown has prompted us to standardize what we believe is a superior solution for patients and clinicians."

Using unique, non-powered Self Adjusting Technology, the AtmosAir Fit MRS delivers uninterrupted therapy—even when transporting a patient or during electrical power outages. A pressurized system of independent, dynamic air cylinders with intake and regulator valves automatically adjusts in reaction to a patient's movements, evenly distributing body weight throughout the mattress and displacing pressure. Combining the AtmosAir Fit MRS and the BariMaxx II Bed helps prevent skin breakdown and facilitate safe patient handling, while maintaining patient dignity.

"The AtmosAir Fit MRS brings value to my practice, economically and in terms of patient outcomes," said Russell Gornichec, M.D., P.C., Weight Loss Center of Oklahoma. "In fact, it is now a standard order for all of my bariatric surgery patients to be placed on a BariMaxx II with an AtmosAir Fit MRS."

For more information about KCI please visit

About KCI

Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world. The company employs 7,100 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit


Kinetic Concepts, Inc.
Media Relations: for journalists only.
Investors Relations: for Investor Relations inquiries.

  • KCI Express
  • Share on
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Notice | Safe Harbor Policy | Contact Us | News Feed

Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.